Alzheimer's disease (AD) is characterized not only by tau and amyloid-β aggregation but also by systemic disruptions in circadian rhythms, metabolism, and gut-brain communication that exacerbate neuroinflammation and neurodegeneration. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.